uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 25, 2013

Weight Loss Supplement Recalled Due To Undeclared Drug

On February 21, 2013, Olaax Corp. issued a voluntary, nationwide recall of the company's weight loss supplement MAXILOSS Weight Advanced softgels because they were found to contain undeclared Sibutramine.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.

The recall includes all authentic and counterfeit packages and lot numbers of the product.

MAXILOSS Weight Advanced softgels were distributed nationwide in the U.S. from January 2011 to November 2012, and known counterfeit versions have been sold online.

Consumers who have purchased this supplement should discontinue use and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

MAXILOSS Weight Advanced softgels also contain lotus leaf, jobstears, bamboo shoots, tarragon, green tea, pysllium husk, ginseng and chromium picolinate. It was promoted as a natural herb for weight loss.

See's Reviews of Weight Loss Supplements, Ginseng Supplements, and Chromium Supplements for tests of related products.

See Related Warnings:

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

Rx Drugs Found in Weight Loss and Enhancement Supplements

Recall of "Slimming" Supplements Spiked with Drug

For more information about this recall, use the link below.